The two upstream regulators—RARA and NKX2-3—appear to play a key role in controlling gene expression in HFD-MSCs and are important for adipocyte metabolism and differentiation; their dysregulation can contribute to metabolic syndrome and inflammation [56–58]. The gene discussed is NKX2-3; the disease is metabolic syndrome.